Kala Pharmaceuticals Inc.
Nanoformulations to treat eye disease
This article was originally published in Start Up
Kala Pharmaceuticals Inc. possesses a nanoparticle technology engineered to enable drugs to penetrate mucosal barriers. Kala intends to open the eye – and other organs protected by mucosal barriers – to a range of new or improved treatments, starting with topical ophthalmic products for both front and back of eye diseases.